Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors
Authors
Keywords
-
Journal
Oncogenesis
Volume 6, Issue 5, Pages e332
Publisher
Springer Nature
Online
2017-05-15
DOI
10.1038/oncsis.2017.30
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interrogating the Druggability of the 2-Oxoglutarate-Dependent Dioxygenase Target Class by Chemical Proteomics
- (2016) Gérard Joberty et al. ACS Chemical Biology
- Epigenomic regulation of oncogenesis by chromatin remodeling
- (2016) R Kumar et al. ONCOGENE
- H2A.Z.1 Monoubiquitylation Antagonizes BRD2 to Maintain Poised Chromatin in ESCs
- (2016) Lauren E. Surface et al. Cell Reports
- BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell
- (2016) Jude T. Deeney et al. PLoS One
- Abrogation of Autophagy by Chloroquine Alone or in Combination with mTOR Inhibitors Induces Apoptosis in Neuroendocrine Tumor Cells
- (2015) Shani Avniel-Polak et al. NEUROENDOCRINOLOGY
- The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models
- (2015) P L Garcia et al. ONCOGENE
- Beating the odds: BETs in disease
- (2015) Chen-Yi Wang et al. TRENDS IN BIOCHEMICAL SCIENCES
- Multi-faceted quantitative proteomics analysis of histone H2B isoforms and their modifications
- (2015) Rosalynn C Molden et al. Epigenetics & Chromatin
- Next generation exome sequencing of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1 reveals different lineages
- (2015) Timon Vandamme et al. Cancer Genetics
- Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines
- (2015) Ganesh K. Boora et al. Cancer Genetics
- JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer
- (2015) Haifeng Qiu et al. Oncotarget
- BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
- (2015) Marie-Magdelaine Coudé et al. Oncotarget
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Comparative drug screening in NUT midline carcinoma
- (2014) A H Beesley et al. BRITISH JOURNAL OF CANCER
- A Cell-Permeable Ester Derivative of the JmjC Histone Demethylase Inhibitor IOX1
- (2014) Rachel Schiller et al. ChemMedChem
- Identification and characterisation of a novel heat shock protein 90 inhibitor ONO4140
- (2014) Rafiqa Eachkoti et al. EUROPEAN JOURNAL OF CANCER
- Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma
- (2014) Dhong Hyun Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Natural Course and Survival of Neuroendocrine Tumors of Thymus and Lung in MEN1 Patients
- (2014) Joanne M. de Laat et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors
- (2014) C Wong et al. Cell Death & Disease
- Neuroendocrine Tumors of the Bronchopulmonary System (Typical and Atypical Carcinoid Tumors): Current Strategies in Diagnosis and Treatment. Conclusions of an Expert Meeting February 2011 in Weimar, Germany
- (2014) Dieter Hörsch et al. Oncology Research and Treatment
- Menin Epigenetically Represses Hedgehog Signaling in MEN1 Tumor Syndrome
- (2013) B. Gurung et al. CANCER RESEARCH
- BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
- (2013) P. Bandopadhayay et al. CLINICAL CANCER RESEARCH
- Neuroendocrine tumours: cracking the epigenetic code
- (2013) A Karpathakis et al. ENDOCRINE-RELATED CANCER
- Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)
- (2013) Rajesh V. Thakker MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients
- (2013) C. M. Gorvin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
- (2013) S. Picaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- (2013) Alexandre Puissant et al. Cancer Discovery
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
- (2013) Daehwan Kim et al. GENOME BIOLOGY
- BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1
- (2013) Helen Jayne Susan Stewart et al. Cancer Medicine
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
- (2012) Panagis Filippakopoulos et al. CELL
- Neuroendocrine tumor disease: an evolving landscape
- (2012) Andrea Frilling et al. ENDOCRINE-RELATED CANCER
- Proliferation Rates of Multiple Endocrine Neoplasia Type 1 (MEN1)-Associated Tumors
- (2012) Gerard V. Walls et al. ENDOCRINOLOGY
- Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit
- (2012) Paul V. Fish et al. JOURNAL OF MEDICINAL CHEMISTRY
- The same pocket in menin binds both MLL and JUND but has opposite effects on transcription
- (2012) Jing Huang et al. NATURE
- Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins
- (2012) Gary LeRoy et al. GENOME BIOLOGY
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modification
- (2011) Minjia Tan et al. CELL
- Bromodomains as therapeutic targets
- (2011) Susanne Muller et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- CBP/p300 and SIRT1 Are Involved in Transcriptional Regulation of S-Phase Specific Histone Genes
- (2011) Hongpeng He et al. PLoS One
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastroenteropancreatic neuroendocrine tumours
- (2008) Irvin M Modlin et al. LANCET ONCOLOGY
- Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene
- (2007) Manuel C. Lemos et al. HUMAN MUTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started